...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith down 50% this morning in US

from US 30 to 15 cents on 31,500 shares.

 

Share
New Message
Please login to post a reply